Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vulvar Neoplasms × DNA × Clear all

Status

Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 3 Carcinoma 3 Neoplasms 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Vulvar Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Teratoma, Ovarian 1 Struma Ovarii 1 Salivary Gland Neoplasms 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Myelodysplastic Syndromes 1 Metabolic Syndrome 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Leukemia 1 Hemangioma, Cavernous, Central Nervous System 1 Glioblastoma 1 Genetic Predisposition to Disease 1 Disease 1 Diabetes Mellitus 1 Cytopenia 1 Cardiovascular Diseases 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Astrocytoma 1

Interventions

Radiotherapy 9 Cisplatin 8 Methods 6 pembrolizumab 5 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 5 Surveys and Questionnaires 4 Papillomavirus Vaccines 4 Early Intervention, Educational 4 Brachytherapy 4 fludarabine 3 Vaccines, Synthetic 3 Vaccines 3 Sentinel Lymph Node Biopsy 3 Radiosurgery 3 Radiation 3 Platinum 3 Palliative Care 3 Nivolumab 3 Indocyanine Green 3 Gemcitabine 3 Cyclophosphamide 3 Carboplatin 3 Bleomycin 3 Biopsy 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 lenvatinib 2 entinostat 2 durvalumab 2 aldesleukin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06582108 2024-09-03

ROAR

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡